Second Circuit: Anti-Kickback Statute Liability Doesn’t Require Corrupt Intent

The Second Circuit rejected Pfizer’s argument that Anti-Kickback Statute liability requires evidence of corrupt intent, explaining that the offer of something of value that could influence a decision was enough to run afoul of the law.